NTR's Q1 net earnings and adjusted EBITDA fall due to lower potash net selling prices in North America, higher phosphate ...

XOMA Royalty (XOMA) delivered earnings and revenue surprises of 123.08% and 159.58%, respectively, for the quarter ended March 2025. Do the numbers hold clues to what lies ahead for the stock?

If you are looking for a stock that has a solid history of beating earnings estimates and is in a good position to maintain ...

Humacyte, Inc. (HUMA) came out with a quarterly loss of $0.10 per share versus the Zacks Consensus Estimate of a loss of $0.19. This compares to loss of $0.29 per share a year ago. These figures are ...

Kinsale Capital's disciplined underwriting and strong broker relationships could catalyze a faster GWP and margin recovery.

Listen below or on the go on Apple Podcasts and SpotifyThis is an abridged transcript of the podcast:Our top story so far, ...

“Our 2025 EPS growth estimate is now above the top-down consensus estimate of 4% and in line with the bottom-up consensus estimate of 7%.” Tariffs have been at the forefront of company concerns during ...

After soaring in 2023 and 2024, shares of Tesla (NASDAQ:TSLA) had been battered throughout Q1 2025. Since the start of the ...

Shares of $127.6 billion Applovin (NASDAQ: APP) are up more than 8% or $28.63 on the day. Momentum stocks like Applovin are ...

The German pharmaceutical and agricultural company said Tuesday that net profit was 1.30 billion euros ($1.44 billion), down from 2 billion euros the previous year and below analysts' forecasts of ...